Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Okubo

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Scientific Reports|November 22, 2019
Area of residual tumor (ART) can predict prognosis after post neoadjuvant therapy resection for pancreatic ductal adenocarcinomaSatoshi Okubo, Motohiro Kojima, Yoko Matsuda, et al.
Journal of Agricultural and Food Chemistry|June 10, 2008
Biochemical and genomic analysis of neoculin compared to monocot mannose-binding lectinsAkiko Shimizu-Ibuka, Yuji Nakai, Keisuke Nakamori, et al.
Molecular and Clinical Oncology|March 21, 2014
Serum iron levels as a new biomarker in chemotherapy with leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan, with or without molecularly-targeted drugsTakumi Ochiai, Kazuhiko Nishimura, Tomoo Watanabe, et al.
Journal of Clinical Medicine|October 29, 2025
A Logistic Regression Model for Predicting Osteoporosis Using Alveolar Bone Mineral Density Measured on Intraoral Radiographs Combined with Panoramic Mandibular Cortical IndexSatoshi Okubo, Satoru Miyabe, Yoshitaka Kise, et al.
Oncology Letters|December 4, 2012
Individualized chemotherapy for colorectal cancer based on the collagen gel droplet-embedded drug sensitivity testTakumi Ochiai, Kazuhiko Nishimura, Tomoo Watanabe, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 3, 2026
[Hepatosplenic T-cell lymphoma with pancytopenia and massive splenomegaly]Misaki Mochida, Daisuke Kaji, Shinsuke Takagi, et al.
Clinical Journal of Gastroenterology|November 7, 2022
Well-preserved liver function enhances the clinical impact of curative-intent subsequent treatment during lenvatinib treatment for unresectable hepatocellular carcinomaYusuke Kawamura, Norio Akuta, Junichi Shindoh, et al.
Oncology|March 1, 2022
Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Early Progressive Disease following Atezolizumab plus Bevacizumab in Patients with Unresectable Hepatocellular CarcinomaYusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, et al.
Oncology|September 14, 2022
The Impact of Lenvatinib on Tumor Blood Vessel Shrinkage of Hepatocellular Carcinoma during Treatment: An Imaging-Based AnalysisNozomu Muraishi, Yusuke Kawamura, Norio Akuta, et al.
Cancers|August 12, 2023
Efficacy of the Combination of Systemic Sequential Therapy and Locoregional Therapy in the Long-Term Survival of Patients with BCLC Stage C Hepatocellular CarcinomaYusuke Kawamura, Norio Akuta, Junichi Shindoh, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Scientific Reports|November 22, 2019
Area of residual tumor (ART) can predict prognosis after post neoadjuvant therapy resection for pancreatic ductal adenocarcinomaSatoshi Okubo, Motohiro Kojima, Yoko Matsuda, et al.
Journal of Agricultural and Food Chemistry|June 10, 2008
Biochemical and genomic analysis of neoculin compared to monocot mannose-binding lectinsAkiko Shimizu-Ibuka, Yuji Nakai, Keisuke Nakamori, et al.
Molecular and Clinical Oncology|March 21, 2014
Serum iron levels as a new biomarker in chemotherapy with leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan, with or without molecularly-targeted drugsTakumi Ochiai, Kazuhiko Nishimura, Tomoo Watanabe, et al.
Journal of Clinical Medicine|October 29, 2025
A Logistic Regression Model for Predicting Osteoporosis Using Alveolar Bone Mineral Density Measured on Intraoral Radiographs Combined with Panoramic Mandibular Cortical IndexSatoshi Okubo, Satoru Miyabe, Yoshitaka Kise, et al.
Oncology Letters|December 4, 2012
Individualized chemotherapy for colorectal cancer based on the collagen gel droplet-embedded drug sensitivity testTakumi Ochiai, Kazuhiko Nishimura, Tomoo Watanabe, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 3, 2026
[Hepatosplenic T-cell lymphoma with pancytopenia and massive splenomegaly]Misaki Mochida, Daisuke Kaji, Shinsuke Takagi, et al.
Clinical Journal of Gastroenterology|November 7, 2022
Well-preserved liver function enhances the clinical impact of curative-intent subsequent treatment during lenvatinib treatment for unresectable hepatocellular carcinomaYusuke Kawamura, Norio Akuta, Junichi Shindoh, et al.
Oncology|March 1, 2022
Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Early Progressive Disease following Atezolizumab plus Bevacizumab in Patients with Unresectable Hepatocellular CarcinomaYusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, et al.
Oncology|September 14, 2022
The Impact of Lenvatinib on Tumor Blood Vessel Shrinkage of Hepatocellular Carcinoma during Treatment: An Imaging-Based AnalysisNozomu Muraishi, Yusuke Kawamura, Norio Akuta, et al.
Cancers|August 12, 2023
Efficacy of the Combination of Systemic Sequential Therapy and Locoregional Therapy in the Long-Term Survival of Patients with BCLC Stage C Hepatocellular CarcinomaYusuke Kawamura, Norio Akuta, Junichi Shindoh, et al.
Pageof 8